
Yonsa
Brand for: Abiraterone acetate micronized
My Prescription
Payment
Select pharmacy



$8,142.33
$30.00 due at pharmacy
$8,142.33 - $30.00 = $8,112.33
$8,112.33 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$8,142.33
Print or send this coupon to your phone
About Yonsa
Drug Details
Abiraterone, marketed under the brand name Zytiga, is an oral medication prescribed for the treatment of certain types of prostate cancer. This drug is specifically used for cancers that rely on testosterone to grow, as well as those that can continue to grow with low levels of testosterone. Abiraterone belongs to a group of medications known as anti-androgens, which work by blocking the production of testosterone, thereby slowing down the growth and spread of prostate cancer. Patients typically take Abiraterone once a day by mouth, alongside a steroid taken once or twice daily. Additionally, some patients may require a medication targeting gonadotropin-releasing hormone (GnRH), unless they have undergone surgery to remove both testicles. It's important to note that this medication is not intended for use by women or children. Common side effects of Abiraterone include high blood pressure and swelling due to fluid retention. While Zytiga is available in generic forms, another version called Yonsa is not. Always consult with a healthcare professional before starting any new medication to ensure it is appropriate for your condition.
Yonsa (Abiraterone Acetate Micronized) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 125MG | 120 Tablets | $8,142.33 | $67.85 |
Yonsa FAQs
Yonsa is used in combination with methylprednisolone to treat metastatic castration-resistant prostate cancer.
Yonsa is not classified as chemotherapy. It is an oral medication used in combination with methylprednisolone to treat metastatic castration-resistant prostate cancer. It works by inhibiting the production of androgens, which can fuel the growth of prostate cancer cells.
Yonsa works by inhibiting the enzyme CYP17, which is involved in the production of androgens, such as testosterone. By reducing androgen levels, Yonsa helps to slow the growth of prostate cancer cells that rely on these hormones to proliferate. It is often used in combination with methylprednisolone to manage side effects and enhance its effectiveness in treating metastatic castration-resistant prostate cancer.
The generic name for Yonsa is abiraterone acetate.
Yonsa is classified as an androgen biosynthesis inhibitor.